Featuring an interview with Dr Asim Farooq, including the following topics:
- Educating patients about ocular toxicities associated with anticancer therapies (0:00)
- Differentiating therapy-related ocular toxicities from symptoms not associated with anticancer drugs (3:44)
- Optimal prevention of ocular toxicities from antibody-drug conjugates; symptoms and management of central serous retinopathy (9:36)
- Pathophysiology of ocular symptoms associated with ALK inhibitors and BRAF/MEK inhibitors (16:40)
- Myths and misperceptions among physicians about ophthalmic toxicities (22:29)
CME information and select publications
Research To Practice | Oncology Videos